Globant has named Sarab Narang as CEO of Glob.AI, its AI-native technology services model aimed at transforming how enterprises adopt and deploy AI. Narang brings over 23 years of experience in AI and enterprise software from roles at ServiceNow, AWS, and KPMG. Under his leadership, Glob.AI plans to scale its AI Pods service units, accelerate enterprise AI adoption, and expand its technology partner ecosystem. This move supports Globant's strategy to drive AI-powered business transformation, with Glob.AI already showing strong revenue growth and adoption among top clients.
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...
IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...
IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...
